| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 2.8K | 3.9% | 8.9% |
| Total Income | 2.8K | 3.9% | 8.9% |
| Expenditure | 3.6K | 17.7% | 22.7% |
| PBT | -775.00 | 520.0% | 518.9% |
| Net Profit | -782.00 | 450.7% | 824.1% |
| OPM | -26.99% | 23.30pp | 32.77pp |
| NPM | -27.55% | 22.75pp | 31.02pp |
| EPS | -6.06 | 445.9% | 821.4% |
Westlake Corporation Reports Third Quarter 2025 Results
04 May 2026 · 4 May, 8:25 am
Summary
Westlake Corporation announced its third quarter 2025 results, reporting net sales of $2.8 billion. The company experienced a net loss of $782 million, or $6.06 per share, and EBITDA of ($431) million, impacted by a non-cash impairment charge. Excluding Identified Items, the net loss was $38 million, or $0.29 per share, and EBITDA was $313 million. Global macroeconomic conditions remained challenging, impacting sales prices and margins in the PEM segment.
Key Highlights
- 1
Westlake Corporation reported net sales of $2.8 billion in the third quarter of 2025.
- 2
The company's net loss was $782 million, or $6.06 per share, for the third quarter of 2025.
- 3
EBITDA was ($431) million, impacted by a non-cash charge of $727 million.
- 4
Excluding Identified Items, the net loss in the third quarter of 2025 was $38 million, or $0.29 per share, and EBITDA was $313 million.
- 5
Housing and Infrastructure Products sales decreased 6% sequentially, driven by a 6% decrease in sales volume.
- 6
Performance and Essential Materials sales decreased 3% over the same period of time as a higher sales volume was more than offset by a 4% decline in average sales price.
- 7
EBITDA excluding Identified Items of $313 million was lower than the third quarter of 2024 EBITDA excluding Identified Items of $580 million.
Management Comments
Jean-Marc Gilson
"Global macroeconomic conditions remained challenging throughout the third quarter of 2025 with continued weakness in industrial and manufacturing activity putting pressure on sales prices and margins in our PEM segment, particularly for chlorovinyls. As a result, during the third quarter we recorded a non-cash impairment charge of $727 million for all of the goodwill associated with PEM's North American Chlorovinyls business. We remain committed to this business as the global need for its products, which are critical to industries ranging from building materials to water to manufacturing, remains intact. We have taken actions to reduce costs to deliver the earnings it is capable of generating and we will assess opportunities to optimize its footprint to return it to levels of profitability that provide an appropriate return on investment." "Our HIP segment performed very well, holding sales in line with the prior-year period against a backdrop of slowing North American residential construction activity. HIP remains well positioned to continue to outgrow the market by 'winning with the winners' through product innovation and our solid position as a preferred supplier to large, national homebuilders and distributors." "Looking ahead to next year, we expect our margins and earnings to be supported by actions that we are taking to improve our profitability. First, better plant reliability should improve EBITDA. Second, we have identified $200 million of cost savings that we expect to achieve in 2026. Third, footprint optimization actions that we have already taken, including the Pernis Shutdown, will remove approximately $100 million of annual losses starting in 2026. We believe that these actions will contribute to margins and earnings next year and for years to come."
Informational and educational content only. Not investment advice.